JPRN-UMIN000003457已完成1 期
Phase I/II trial of oral hydroxyurea in combination with pegylated interferon and ribavirin in chronic hepatitis C patients - Phase I/II trial of oral hydroxyurea in combination with pegylated interferon and ribavirin in chronic hepatitis C patients
Yokohama City University Medical Center Gastroenterological Center0 个研究点目标入组 20 人开始时间: 2010年4月9日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Pregnant or lactating Women 2)Patients with uncontrolled heart disease 3)Patients with uncontorolled DM or HT 4)Patients with inadequate haematological status 5) Patients with exclusion criteria for PEG/RBV therapy 6) Patient with decision of exclusion
研究者
相似试验
已完成
1 期
The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected PatientsHIV InfectionsNCT00001074National Institute of Allergy and Infectious Diseases (NIAID)140
撤回
1 期
A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid TumorsAdvanced Solid TumorsNCT01521299Dartmouth-Hitchcock Medical Center
已完成
2 期
Phase 2 study of pretreatment with hydroxyurea prior to induction therapy for patients with newly diagnosed acute myeloid leukemia (PREFACE study)Acute myeloid leukemiaJPRN-UMIN000012389Fujita Health University School of Medicine26
尚未招募
不适用
International study in multiple centers studying the effect of hydroxy-urea and temozolomide chemotherapy in patients with a recurrent malignant brain tumor (Glioblastoma)Brain tumor, glioma, glioblastoma, recurrent glioblastoma, glioblastoma multiformeHersentumor, glioom, glioblastoom, recidief glioblastoom, glioblastoma multiformeNL-OMON20720VU University Medical Center35
已完成
不适用
International Multicenter Phase I trial of Hydroxyurea in Combination with Dose-Intense Temozolomide in Recurrent Glioblastoma.High grade glioma10029211brain tumorNL-OMON50467Vrije Universiteit Medisch Centrum49